Jove
Visualize
お問い合わせ

関連する概念動画

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Ultrasound-guided quadratus lumboum block versus transversus abdominis plane block for post-operative analgesia in patients undergoing total abdominal hysterectomy: A systematic review and meta-analysis.

European journal of obstetrics & gynecology and reproductive biology: X·2026
Same author

Analytical evaluation of the impact of formaldehyde exposure on general health and sleep quality: the moderating role of physical activity.

International archives of occupational and environmental health·2025
Same author

Deciphering Persistent D-Dimer Elevation in Paraquat Poisoning: A Mortality Assessment Case Study.

Clinical case reports·2025
Same author

An evaluation of photobiomodulation effects on human gingival fibroblast cells under hyperglycemic condition: an in vitro study.

Lasers in medical science·2023
Same author

Robotized polarization characterization platform for free-space quantum communication optics.

The Review of scientific instruments·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

薬物開発

Kimia Mohammadi1

  • 1Kimiagar Toos Pharmaceutical Company, Mashhad, Khorasan Razavi, Iran (Islamic Republic of).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
まとめ
この要約は機械生成です。

本研究では、アルツハイマー病治療のための選択的ROCK 2阻害剤を開発した。最も選択性の高い化合物は19のキナーゼを阻害し、副作用の軽減の可能性を示した。

キーワード:
アルツハイマー病ROCK 2阻害剤選択的阻害剤キナーゼスクリーニング薬物開発

さらに関連する動画

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

関連する実験動画

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学分野:

  • 生化学; 薬理学; 神経科学

背景:

  • Rho関連キナーゼ(ROCK)は、細胞プロセスに不可欠であり、神経変性疾患に関与しています。ROCKシグナル伝達はアルツハイマー病(AD)の進行を悪化させます。ROCK 2阻害は、オートファジーを増強し、神経炎症を低下させることにより、ADの治療の可能性を提供します。

研究 の 目的:

  • 潜在的なアルツハイマー病治療のためのROCK 2選択的阻害剤の設計と特定。ROCK 1とROCK 2の構造的類似性の課題に対処し、選択的阻害を達成する。キナーゼ選択性スクリーニングを通じてオフターゲットの副作用を最小限に抑える。

主な方法:

  • 既知のROCK2阻害剤と官能基に着想を得て63個の化合物を設計しました。PDB由来の23個のキナーゼタンパク質構造に対して仮想スクリーニング(ドッキング)を利用しました。ドッキングスコアと阻害定数(Ki比>10)に基づいて阻害剤の選択性を評価しました。

主要な成果:

  • 17個の化合物が、他のキナーゼに対するROCK 2の選択性において様々な選択性を示しました。化合物「Peic」は、19個のキナーゼに対してKi > 10の高い選択性を示しました。化合物「Si」は、4個のキナーゼに対してのみKi > 10であり、選択性が最も低かったです。

結論:

  • 上位17個の化合物は、4から19個のキナーゼにわたる有望な効力と選択性を示しました。これらの選択的ROCK 2阻害剤は、アルツハイマー病治療の候補となる可能性があります。開発された化合物は、選択性により、副作用が少なくADの症状を軽減する可能性があります。